ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

CTO Tclarke Plc

159.00
-1.00 (-0.62%)
21 Jun 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Tclarke Plc LSE:CTO London Ordinary Share GB0002015021 ORD 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -1.00 -0.62% 159.00 159.00 160.50 159.50 159.00 159.00 187,349 16:35:15
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Special Trade Contractor,nec 491M 6.5M 0.1169 13.64 88.66M
Tclarke Plc is listed in the Special Trade Contractor sector of the London Stock Exchange with ticker CTO. The last closing price for Tclarke was 160p. Over the last year, Tclarke shares have traded in a share price range of 105.00p to 167.50p.

Tclarke currently has 55,588,827 shares in issue. The market capitalisation of Tclarke is £88.66 million. Tclarke has a price to earnings ratio (PE ratio) of 13.64.

Tclarke Share Discussion Threads

Showing 5101 to 5124 of 5125 messages
Chat Pages: 205  204  203  202  201  200  199  198  197  196  195  194  Older
DateSubjectAuthorDiscuss
18/6/2024
18:11
So its £1.60 a share, upto 14 days from 25th June..
igoe104
07/6/2024
10:20
I assume that MS are just holding those for the buyer or can we get a little excited?
tiswas
05/6/2024
09:59
Another hedge fund purchase of 1% of the capital yesterday.Long odds bet on a higher offer??
bsdjj
21/5/2024
14:08
Sadly I can not see anyone trumping the 160p offer. Regent obviously have their 21% and management are probably rooting for them.

Question is sell and move on if it is dead money or hang on in the unlikely event that someone makes Regent pay more?

tiswas
13/5/2024
17:06
Trading above bid + divi price.

Interesting....

thorpematt
13/5/2024
13:41
also voted against
janeann
07/5/2024
18:35
Funds will except the deal. They have already consulted them before hand.
igoe104
07/5/2024
17:24
Vote papers against, sent. Can only hope holders of enough shares decide to vote against. Probably too many for though.
geminian
07/5/2024
15:21
Voted against
forensic
02/5/2024
17:26
IC view -
The exit multiple is hardly generous at 6.6 times earnings estimates and TClarke has net cash of £19.3mn, a sum equating to 21 per cent of the offer price. The fact that the final dividend of 4.5p is being paid is immaterial as it’s owed to shareholders for the 2023 financial year. I would vote against the scheme of arrangement.

davebowler
02/5/2024
10:29
The directors cash in a stack of options and presumably are being looked after by a long term major shareholder. I think they know exactly what they are doing, float it again in a few years time at double or treble the price and make a killing again.
tiswas
02/5/2024
10:04
Yes a very low bid. The directors must be insane to accept.
kneecaps2
02/5/2024
07:35
I;m voting my shares against too.
18bt
01/5/2024
17:27
Having read an article on gg2.net where amongst other comments Deep Valecha says T Clarke is a well run company, my thoughts are that T Clarke is being sold off far too cheaply. While not holding enough shares to make any real difference, will be voting against the sale. Article found on Google search: Regent Gas Aquisitions - scroll down results to heading gg2.net - Deep Valecha’s Regent Group to acquire T Clarke for £90.56m - GG2
geminian
30/4/2024
17:00
I notice that Simon Thompson in the Inv Chronicle shares my view that quoting the historic P/E does not adequately reflect their prospects and thus serves to disguise the paucity of the offer:

"The acquirer states that the 160p-a-share take-out price equates to 11.6 times last year’s earnings per share (EPS), but it makes no reference to the fact that earnings were depressed. In fact, pre-tax profit is forecast to bounce back from £7.6mn to £17.1mn in 2024 to drive a 75 per cent rebound in EPS to 24.1p. The exit multiple is hardly generous at 6.6 times earnings estimates and TClarke has net cash of £19.3mn, a sum equating to 21 per cent of the offer price. The fact that the final dividend of 4.5p is being paid is immaterial as it’s owed to shareholders for the 2023 financial year. I would vote against the scheme of arrangement."

hxxps://www.investorschronicle.co.uk/ideas/2024/04/29/tclarke-s-cash-offer-is-easy-to-refuse/?xnpe_tifc=xuodbuP.4dQsbIojbdnlbMpsafeWaeiWhFW.RyPWVZ7DRuUcRdscVlBNEkscEkUZauUltu4vaMXDbuhuxFULhkesbDLuxkn8&utm_source=exponea&utm_campaign=IC%20-%20The%20Trader%20-%20Newsletter%2030.04.24&utm_medium=email

GLA

petomi
25/4/2024
09:26
SO that is 3m odd of nil cost options that the directors can cash in if I am reading that right? Nearly £5m!

I had better not say what I am thinking!

tiswas
23/4/2024
15:19
CTO ramping up the news flow this week. Let's hope it helps bring in more bidders....

Prestigious London contract win:



TClarke Healthcare tech in 80% + of all new UK scanning facilities:

rivaldo
19/4/2024
12:29
Now up to 2% and share price above offer price, so have they bought some more this morning? A number of sells at just above the offer price.
18bt
18/4/2024
08:08
I assume they are not there just to collect the 4.5p dividend......
bsdjj
17/4/2024
17:28
Someone bought 1.7%??
bsdjj
16/4/2024
15:28
well i first bought these in 2013 ..... at 62p, but very disappointed at todays price. bit of a rollercoaster ride but plenty of dividends on the way. A very sad day
janeann
16/4/2024
13:08
Salpara, your moaning about a price of £1.60 for a takeover, but you and lots of others weren't interested in buying these in the mid 120s. 🤷
igoe104
16/4/2024
12:46
Well I sold out last week after 2 years of underperformance. Impeccable timing. Seemed to be a vanity project with high turnover, low profits and fat director salaries. Much to my annoyance its seems another company sees value where I didn't
dr biotech
16/4/2024
12:07
Watched this for some time but never took a stake.
I am amazed that the BOD are recommending this really poor premium when the share price was near a multi year low. The only conclusion one can reach is that current/forward prospects are not anywhere near as positive as the market has been led to believe.

salpara111
Chat Pages: 205  204  203  202  201  200  199  198  197  196  195  194  Older

Your Recent History

Delayed Upgrade Clock